Overview
Isolated childhood apraxia of speech (CAS), also known as developmental verbal dyspraxia or developmental apraxia of speech, is a rare neurological speech sound disorder that affects a child's ability to plan and coordinate the precise movements needed for speech production. Unlike other speech disorders caused by muscle weakness or paralysis, CAS involves a disruption in the brain's motor planning pathways that control the sequencing and timing of movements of the lips, tongue, jaw, and palate required for intelligible speech. The disorder primarily affects the nervous system's speech-motor programming centers. Key clinical features include inconsistent speech sound errors, difficulty achieving and maintaining articulatory configurations, inappropriate prosody (especially in the realization of lexical or phrasal stress), groping or searching oral movements when attempting speech, limited consonant and vowel repertoire, and significant gaps between receptive language abilities (which are often relatively preserved) and expressive speech abilities. Children with CAS may say the same word differently each time they attempt it, and longer or more complex words and phrases are typically more difficult to produce. Some children may also exhibit fine and gross motor coordination difficulties, though the speech impairment is the defining feature. There is no cure for isolated childhood apraxia of speech, but early and intensive speech-language therapy is the cornerstone of management. Evidence-based treatment approaches focus on improving motor planning and programming for speech through frequent, intensive practice of speech movements, often incorporating multisensory feedback (tactile, visual, and auditory cues). Approaches such as Dynamic Temporal and Tactile Cueing (DTTC), the Nuffield Dyspraxia Programme, and Rapid Syllable Transition Treatment (ReST) have shown effectiveness. Some cases of CAS have been associated with variants in the FOXP2 gene, though many cases remain idiopathic. Prognosis varies depending on severity and the intensity of intervention, but many children make significant progress with appropriate therapy.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Isolated childhood apraxia of speech.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Isolated childhood apraxia of speech at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Isolated childhood apraxia of speech.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Isolated childhood apraxia of speech.
Community
No community posts yet. Be the first to share your experience with Isolated childhood apraxia of speech.
Start the conversation →Latest news about Isolated childhood apraxia of speech
No recent news articles for Isolated childhood apraxia of speech.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Isolated childhood apraxia of speech
What is Isolated childhood apraxia of speech?
Isolated childhood apraxia of speech (CAS), also known as developmental verbal dyspraxia or developmental apraxia of speech, is a rare neurological speech sound disorder that affects a child's ability to plan and coordinate the precise movements needed for speech production. Unlike other speech disorders caused by muscle weakness or paralysis, CAS involves a disruption in the brain's motor planning pathways that control the sequencing and timing of movements of the lips, tongue, jaw, and palate required for intelligible speech. The disorder primarily affects the nervous system's speech-motor p
At what age does Isolated childhood apraxia of speech typically begin?
Typical onset of Isolated childhood apraxia of speech is childhood. Age of onset can vary across affected individuals.